Bedrest for Muscle Atrophy
(FABRIC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how bedrest affects muscles in healthy young adults. Researchers aim to determine changes in muscle size, strength, and endurance when participants remain in bed for five days. They also examine how the body manages insulin (a hormone that controls blood sugar) and how muscles produce energy during this period. This trial suits generally healthy adults aged 18-30 who exercise recreationally and maintain a stable body weight. As an unphased study, it offers a unique opportunity to contribute to the scientific understanding of muscle health and energy use.
Will I have to stop taking my current medications?
The trial requires that you do not use medications that affect muscle protein turnover or anticoagulant medications. If you are on such medications, you may need to stop taking them to participate.
What prior data suggests that bedrest is safe for healthy, young adults?
Research shows that short-term bedrest, such as five days, is usually safe for healthy individuals. Studies have found that staying in bed can lead to muscle weakness, which can start quickly, sometimes within just a few days. However, these changes are usually temporary and reversible. For example, muscle shrinking and weakness have appeared in various studies, but participants did not experience serious problems during these rest periods.
While losing some muscle and strength is common, these effects are generally not harmful in the short term for healthy adults. The body typically returns to normal once regular activities resume. Overall, when properly monitored, bedrest in these trials is considered safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about the bedrest protocol for muscle atrophy because it offers a unique way to understand how strict inactivity impacts muscles over a short time. Unlike other treatments that might involve physical therapy or medications targeting muscle preservation, this approach provides a controlled environment to observe muscle changes and recovery. By monitoring diet and activity closely, researchers hope to uncover insights into muscle deterioration and recovery, potentially leading to new strategies for preventing or reversing muscle loss.
What evidence suggests that bedrest is effective for studying muscle atrophy?
Research has shown that staying in bed can quickly weaken muscles and cause them to shrink. One study found that after just five days of bedrest, both young and older adults lost 9–14% of their muscle strength. Another study found that one week of bedrest significantly reduced muscle size and made it harder for the body to use insulin to control blood sugar. These findings suggest that even short periods of bedrest can lead to noticeable muscle loss and affect how the body handles sugar. Participants in this trial will undergo a 19-day study period, including 5 days of strict bedrest, to further investigate these effects.12678
Who Is on the Research Team?
Chris McGlory, PhD.
Principal Investigator
Queen's University
Are You a Good Fit for This Trial?
This trial is for healthy, young adults interested in how bedrest affects muscle and insulin response. Participants must be willing to undergo MRI scans, strength tests, glucose oxidation studies, muscle biopsies, and blood sampling before and after a control period and 5 days of strict bedrest.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Control
Participants undergo baseline testing and a free-living control period with habitual daily activities
Bedrest
Participants undergo 5 days of strict horizontal bedrest with controlled diet and monitored physical activity
Follow-up
Participants are monitored for changes in muscle mass, strength, and metabolic function after bedrest
What Are the Treatments Tested in This Trial?
Interventions
- Bedrest
Find a Clinic Near You
Who Is Running the Clinical Trial?
Queen's University
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator